These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 19492858)
21. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques. Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822 [TBL] [Abstract][Full Text] [Related]
22. Minor contribution of HLA class I-associated selective pressure to the variability of HIV-1 accessory protein Vpu. Hasan Z; Carlson JM; Gatanaga H; Le AQ; Brumme CJ; Oka S; Brumme ZL; Ueno T Biochem Biophys Res Commun; 2012 May; 421(2):291-5. PubMed ID: 22503975 [TBL] [Abstract][Full Text] [Related]
23. Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains. Gomez LM; Pacyniak E; Flick M; Hout DR; Gomez ML; Nerrienet E; Ayouba A; Santiago ML; Hahn BH; Stephens EB Virology; 2005 Apr; 335(1):46-60. PubMed ID: 15823605 [TBL] [Abstract][Full Text] [Related]
24. Structural implications of mutations assessed by molecular dynamics: Vpu1-32 from HIV-1. Krüger J; Fischer WB Eur Biophys J; 2010 Jun; 39(7):1069-77. PubMed ID: 19506851 [TBL] [Abstract][Full Text] [Related]
25. HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin. Fritz JV; Tibroni N; Keppler OT; Fackler OT Virology; 2012 Mar; 424(1):33-44. PubMed ID: 22222210 [TBL] [Abstract][Full Text] [Related]
26. A molecular clone of simian-human immunodeficiency virus (DeltavpuSHIV(KU-1bMC33)) with a truncated, non-membrane-bound vpu results in rapid CD4(+) T cell loss and neuro-AIDS in pig-tailed macaques. McCormick-Davis C; Dalton SB; Hout DR; Singh DK; Berman NE; Yong C; Pinson DM; Foresman L; Stephens EB Virology; 2000 Jun; 272(1):112-26. PubMed ID: 10873754 [TBL] [Abstract][Full Text] [Related]
27. Structural and functional characterization of human SGT and its interaction with Vpu of the human immunodeficiency virus type 1. Dutta S; Tan YJ Biochemistry; 2008 Sep; 47(38):10123-31. PubMed ID: 18759457 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and characterization of the hydrophilic C-terminal domain of the human immunodeficiency virus type 1-encoded virus protein U (Vpu). Henklein P; Schubert U; Kunert O; Klabunde S; Wray V; Klöppel KD; Kiess M; Portsmann T; Schomburg D Pept Res; 1993; 6(2):79-87. PubMed ID: 8387359 [TBL] [Abstract][Full Text] [Related]
29. Molecular dynamics investigation of membrane-bound bundles of the channel-forming transmembrane domain of viral protein U from the human immunodeficiency virus HIV-1. Lopez CF; Montal M; Blasie JK; Klein ML; Moore PB Biophys J; 2002 Sep; 83(3):1259-67. PubMed ID: 12202353 [TBL] [Abstract][Full Text] [Related]
30. Atomistic detailed mechanism and weak cation-conducting activity of HIV-1 Vpu revealed by free energy calculations. Padhi S; Burri RR; Jameel S; Priyakumar UD PLoS One; 2014; 9(11):e112983. PubMed ID: 25392993 [TBL] [Abstract][Full Text] [Related]
32. The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function. Raja NU; Jabbar MA Virology; 1996 Jun; 220(1):141-51. PubMed ID: 8659106 [TBL] [Abstract][Full Text] [Related]
33. NMR studies for identifying phosphopeptide ligands of the HIV-1 protein Vpu binding to the F-box protein beta-TrCP. Evrard-Todeschi N; Gharbi-Benarous J; Bertho G; Coadou G; Megy S; Benarous R; Girault JP Peptides; 2006 Jan; 27(1):194-210. PubMed ID: 16165251 [TBL] [Abstract][Full Text] [Related]
34. Probing interactions of Vpu from HIV-1 with amiloride-based compounds. Rosenberg MR; Weaver LM; Casarotto MG Biochim Biophys Acta; 2016 Apr; 1858(4):733-9. PubMed ID: 26724207 [TBL] [Abstract][Full Text] [Related]
35. Conformational changes induced by a single amino acid substitution in the trans-membrane domain of Vpu: implications for HIV-1 susceptibility to channel blocking drugs. Park SH; Opella SJ Protein Sci; 2007 Oct; 16(10):2205-15. PubMed ID: 17766368 [TBL] [Abstract][Full Text] [Related]
36. Epitope mapping of the phosphorylation motif of the HIV-1 protein Vpu bound to the selective monoclonal antibody using TRNOESY and STD NMR spectroscopy. Gharbi-Benarous J; Bertho G; Evrard-Todeschi N; Coadou G; Megy S; Delaunay T; Benarous R; Girault JP Biochemistry; 2004 Nov; 43(46):14555-65. PubMed ID: 15544326 [TBL] [Abstract][Full Text] [Related]
37. Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIVTM) that is less pathogenic for pig-tailed macaques. Hout DR; Gomez ML; Pacyniak E; Gomez LM; Inbody SH; Mulcahy ER; Culley N; Pinson DM; Powers MF; Wong SW; Stephens EB Virology; 2005 Aug; 339(1):56-69. PubMed ID: 15975620 [TBL] [Abstract][Full Text] [Related]
38. Molecular dynamics simulations reveal the HIV-1 Vpu transmembrane protein to form stable pentamers. Padhi S; Khan N; Jameel S; Priyakumar UD PLoS One; 2013; 8(11):e79779. PubMed ID: 24223193 [TBL] [Abstract][Full Text] [Related]
39. HIV accessory genes Vif and Vpu. Strebel K Adv Pharmacol; 2007; 55():199-232. PubMed ID: 17586316 [No Abstract] [Full Text] [Related]
40. Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers. Lu JX; Sharpe S; Ghirlando R; Yau WM; Tycko R Protein Sci; 2010 Oct; 19(10):1877-96. PubMed ID: 20669237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]